The Mesothelioma Applied Research Foundation (Meso Foundation, formerly MARF) is a non-profit organization that funds mesothelioma research, provides services to patients, educates the public, and advocates in Washington, DC for governmental funding for mesothelioma research. The organization's mission is to eradicate mesothelioma, a cancer caused by exposure to asbestos, as a life-ending disease,

Its donors include lawyers, companies that have manufactured asbestos and victims, along with their family and friends.

The Mesothelioma Applied Research Foundation (MARF) was formed in late 1999 to restore hope and end the misery for mesothelioma patients and their families. Our mission is to eradicate mesothelioma as a life-ending disease through research, education and awareness. We are accomplishing this by collaborating with doctors, scientists, asbestos trial lawyers and manufacturers, labor unions, drug companies, the Government, and mesothelioma patients and family members themselves. These parties may be divided on various issues, but one thing is certain: patients diagnosed with this terrible tumor will not have a realistic hope for a cure until we commit the research money necessary to find a cure.

How Do We End The Apathy?

The resources to find a cure are available. Millions of dollars are spent every year on asbestos litigation and lobbying. Would not at least some of this money be better invested in finding a cure? There are intelligent and passionate doctors and scientists who believe that a cure can be found. The Federal Government budgets millions of dollars for cancer research; more of this can be invested in helping our Navy veterans win the battle against mesothelioma.

It is a question of will and funding. MARF unites all the interested parties with one goal: to find a cure and stop the pointless suffering. MARF's science advisors have faith that the tumor does have an Achilles' heel; it is only a matter of finding it.

To date, the foundation has funded over $5 million in clinical research and is the host of the annual International Symposium on Malignant Mesothelioma